Biopharma is a fast-growing world where big ideas come along daily. Our readers rely on Fierce Biotech for the latest news, analysis and data on drugs and the companies that make them. Fierce Biotech covers the biopharma waterfront, from drug development through the entire lifecycle—tracking regulatory approvals, payer negotiations, manufacturing, marketing, patent fights, government investigations and regulation, M&A deals and beyond. Our aim is to analyze the day's news, showing readers not only what they need to know, but why they need to know it. Beyond the daily, the Fierce Biotech team produces special reports that take stock of the industry's products and finances, and shed new light on industry trends.
